GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 58 filers reported holding GEMINI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,000 | -63.5% | 16,600 | -61.9% | 0.00% | – |
| Q2 2022 | $74,000 | +221.7% | 43,602 | +162.1% | 0.00% | – |
| Q1 2022 | $23,000 | -93.6% | 16,633 | -86.6% | 0.00% | – |
| Q4 2021 | $360,000 | -52.7% | 123,710 | -34.4% | 0.00% | – |
| Q3 2021 | $761,000 | +54.7% | 188,632 | +148.1% | 0.00% | – |
| Q2 2021 | $492,000 | -16.3% | 76,026 | +75.3% | 0.00% | – |
| Q1 2021 | $588,000 | – | 43,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Running Point Capital Advisors, LLC | 10,000 | $13,500 | 0.01% |
| Ulland Investment Advisors, LLC | 0 | $0 | 0.00% |